All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ3010 | Anti-SRSF10 (CBXS-3824) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3824 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3011 | Anti-SRSF10 (CBXS-0719) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0719 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3012 | Anti-SRSF10 (CBXF-1035) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXF-1035 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3013 | Anti-SRSF10 (CBXF-3298) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXF-3298 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3014 | Anti-SRSF10 (CBXF-3299) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXF-3299 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6434 | Anti-SRSF10 (CBXS-3824) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3824 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6435 | Anti-SRSF10 (CBXS-0719) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0719 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6436 | Anti-SRSF10 (CBXF-1035) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXF-1035 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6437 | Anti-SRSF10 (CBXF-3298) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXF-3298 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6438 | Anti-SRSF10 (CBXF-3299) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXF-3299 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION